1. Home
  2. THFF vs CRMD Comparison

THFF vs CRMD Comparison

Compare THFF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THFF
  • CRMD
  • Stock Information
  • Founded
  • THFF 1984
  • CRMD 2006
  • Country
  • THFF United States
  • CRMD United States
  • Employees
  • THFF N/A
  • CRMD N/A
  • Industry
  • THFF Major Banks
  • CRMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • THFF Finance
  • CRMD Health Care
  • Exchange
  • THFF Nasdaq
  • CRMD Nasdaq
  • Market Cap
  • THFF 625.8M
  • CRMD 973.3M
  • IPO Year
  • THFF N/A
  • CRMD 2010
  • Fundamental
  • Price
  • THFF $56.98
  • CRMD $11.40
  • Analyst Decision
  • THFF Buy
  • CRMD Strong Buy
  • Analyst Count
  • THFF 2
  • CRMD 7
  • Target Price
  • THFF $56.50
  • CRMD $17.33
  • AVG Volume (30 Days)
  • THFF 56.2K
  • CRMD 2.5M
  • Earning Date
  • THFF 07-22-2025
  • CRMD 08-13-2025
  • Dividend Yield
  • THFF 3.58%
  • CRMD N/A
  • EPS Growth
  • THFF N/A
  • CRMD N/A
  • EPS
  • THFF 4.63
  • CRMD 0.28
  • Revenue
  • THFF $215,577,000.00
  • CRMD $82,553,827.00
  • Revenue This Year
  • THFF $29.97
  • CRMD $238.38
  • Revenue Next Year
  • THFF $2.84
  • CRMD $53.52
  • P/E Ratio
  • THFF $12.30
  • CRMD $41.86
  • Revenue Growth
  • THFF 9.26
  • CRMD N/A
  • 52 Week Low
  • THFF $35.62
  • CRMD $3.61
  • 52 Week High
  • THFF $57.16
  • CRMD $17.43
  • Technical
  • Relative Strength Index (RSI)
  • THFF 74.79
  • CRMD 39.52
  • Support Level
  • THFF $52.66
  • CRMD $12.14
  • Resistance Level
  • THFF $54.63
  • CRMD $17.43
  • Average True Range (ATR)
  • THFF 1.40
  • CRMD 0.69
  • MACD
  • THFF 0.45
  • CRMD -0.51
  • Stochastic Oscillator
  • THFF 97.58
  • CRMD 4.60

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: